null

SMILES: CN(C)C[C@@H](O)Cn1cc(C2CCN(CC3CCCCCCC3)CC2)c2cc(F)ccc12

InChI Key: InChIKey=YEOANUDQDGQSQW-XMMPIXPASA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50185789   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Nociceptin receptor (Homo sapiens (Human))	BDBM50185789 ((R)-1-(3-(1-(cyclooctylmethyl)piperidin-4-yl)-5-fl...) Show SMILES CN(C)C[C@@H](O)Cn1cc(C2CCN(CC3CCCCCCC3)CC2)c2cc(F)ccc12 Show InChI InChI=1S/C27H42FN3O/c1-29(2)18-24(32)19-31-20-26(25-16-23(28)10-11-27(25)31)22-12-14-30(15-13-22)17-21-8-6-4-3-5-7-9-21/h10-11,16,20-22,24,32H,3-9,12-15,17-19H2,1-2H3/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	970	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Agonist activity at ORL1 receptor expressed in HEK293 cells by calciun flux assay				Bioorg Med Chem Lett 16: 3524-8 (2006) Article DOI: 10.1016/j.bmcl.2006.03.094 BindingDB Entry DOI: 10.7270/Q2VT1RQJ
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM50185789 ((R)-1-(3-(1-(cyclooctylmethyl)piperidin-4-yl)-5-fl...) Show SMILES CN(C)C[C@@H](O)Cn1cc(C2CCN(CC3CCCCCCC3)CC2)c2cc(F)ccc12 Show InChI InChI=1S/C27H42FN3O/c1-29(2)18-24(32)19-31-20-26(25-16-23(28)10-11-27(25)31)22-12-14-30(15-13-22)17-21-8-6-4-3-5-7-9-21/h10-11,16,20-22,24,32H,3-9,12-15,17-19H2,1-2H3/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	1.90E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]U-69593 from kappa opioid receptor expressed in HEK293 cells				Bioorg Med Chem Lett 16: 3524-8 (2006) Article DOI: 10.1016/j.bmcl.2006.03.094 BindingDB Entry DOI: 10.7270/Q2VT1RQJ
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM50185789 ((R)-1-(3-(1-(cyclooctylmethyl)piperidin-4-yl)-5-fl...) Show SMILES CN(C)C[C@@H](O)Cn1cc(C2CCN(CC3CCCCCCC3)CC2)c2cc(F)ccc12 Show InChI InChI=1S/C27H42FN3O/c1-29(2)18-24(32)19-31-20-26(25-16-23(28)10-11-27(25)31)22-12-14-30(15-13-22)17-21-8-6-4-3-5-7-9-21/h10-11,16,20-22,24,32H,3-9,12-15,17-19H2,1-2H3/t24-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	2.70E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]DAMGO from mu opioid receptor expressed in HEK293 cells				Bioorg Med Chem Lett 16: 3524-8 (2006) Article DOI: 10.1016/j.bmcl.2006.03.094 BindingDB Entry DOI: 10.7270/Q2VT1RQJ
					More data for this Ligand-Target Pair
Delta-type opioid receptor (Homo sapiens (Human))	BDBM50185789 ((R)-1-(3-(1-(cyclooctylmethyl)piperidin-4-yl)-5-fl...) Show SMILES CN(C)C[C@@H](O)Cn1cc(C2CCN(CC3CCCCCCC3)CC2)c2cc(F)ccc12 Show InChI InChI=1S/C27H42FN3O/c1-29(2)18-24(32)19-31-20-26(25-16-23(28)10-11-27(25)31)22-12-14-30(15-13-22)17-21-8-6-4-3-5-7-9-21/h10-11,16,20-22,24,32H,3-9,12-15,17-19H2,1-2H3/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]DDPDE from delta opioid receptor expressed in HEK293 cells				Bioorg Med Chem Lett 16: 3524-8 (2006) Article DOI: 10.1016/j.bmcl.2006.03.094 BindingDB Entry DOI: 10.7270/Q2VT1RQJ
					More data for this Ligand-Target Pair